United States · Investor

Ascent Biomedical Ventures

Last cheque observed Apr 2014. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

GrowthPre-seedSeedConsumerFinTechFinance & Crypto

Cheques on record
0%of best year0cheques in 12 months, 12 on record
Since the last cheque4576days00hrs00min00sec
Median round$9.5MRounds led0 of 12Sole investor1 roundsExits1 from the portfolioMostly inUnited States, 91%
Pitch Ascent Biomedical Ventures

Ascent Biomedical Ventures highlights

  1. 01

    12 rounds on record

  2. 02

    Mostly Series B and Series A: 58% of its rounds

  3. 03

    Sole investor in 1 rounds, median $1.2M

  4. 04

    1 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
GrowthPre-seedSeedSeries ASeries B
Sectors
ConsumerFinTechFinance & Crypto
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first12 appearances

  1. 2014

    1 round

  2. Apr
    eCaringSeries A · US$3.5MWith 1 other
  3. 2013

    2 rounds

  4. Dec
    CovagenSeries B · CH · pehub.com$47MWith 7 others
  5. Dec
    XlumenaSeries C · US · finsmes.com$25MWith 4 others
  6. 2012

    1 round

  7. Jul
    CoferonSeries B · US · marketwire.com$12MWith 2 others
  8. 2011

    1 round

  9. Apr
    XlumenaSeries B · US · pehub.com$7.0MWith 4 others
  10. 2010

    1 round

  11. Jul
    Cara TherapeuticsSeries D · US · fiercebiotech.com$15MWith 7 others
  12. 2009

    1 round

  13. Mar
    TargAnoxSeries A · US · xconomy.com$5.1MWith 1 other
  14. 2008

    1 round

  15. Jul
    Cara TherapeuticsSeries C · US$12MWith 3 others
  16. 2007

    1 round

  17. Jul
    OuroborosSeries A · US$1.2MSole investor
  18. 2006

    1 round

  19. Nov
    Cara TherapeuticsSeries C · US · thefreelibrary.com$19MWith 4 others
  20. 2005

    1 round

  21. Dec
    Cara TherapeuticsSeries B · US$4.7MWith 1 other
  22. 2003

    1 round

  23. Jul
    EntigoVenture$3.0MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

CovagenBought by CilagUndisclosedAug 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Ascent Biomedical Ventures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Ascent Biomedical Ventures

What does Ascent Biomedical Ventures invest in?

Ascent Biomedical Ventures invests most often at Series B and Series A (58% of the rounds on record), in sectors such as Consumer, FinTech and Finance & Crypto.

How active is Ascent Biomedical Ventures?

12 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2014.

How big are Ascent Biomedical Ventures's cheques?

The median round it joins is $9.5M.

Does Ascent Biomedical Ventures lead rounds?

Rarely, if at all: none of its 12 investments on record names it as the lead.

Where does Ascent Biomedical Ventures invest?

Most of the companies it backs are in the United States (91%) and Switzerland (9%).

Is Ascent Biomedical Ventures investing now?

No investments in the last 12 months; the latest was in Apr 2014.

Who does Ascent Biomedical Ventures invest alongside?

Most often Alta Partners (2 rounds together), Aperture Venture Partners (2 rounds together) and Charter Life Sciences (2 rounds together).

What kind of investor is Ascent Biomedical Ventures?

Ascent Biomedical Ventures is a VC firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it